Skip to main content

Christopher Chidley

Assistant Professor of Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
308 Research Drive, Durham, NC 27710

Overview


Chris Chidley is an Assistant Professor in the Department of Pharmacology and Cancer Biology since September 2024.

The Chidley lab investigates the role of transporter proteins in nutrient and metabolite import/export and their impact on cell physiology and response to chemotherapeutics. The lab uses unbiased genetic screening in cell and animal models along with biochemistry, cell biology, and analytical chemistry tools to identify critical small molecule transporters across different environments, characterize their function, and explore how the tumor microenvironment impacts cancer metabolism. Our research aims to guide the development of metabolic strategies to suppress tumor growth, and aid precision medicine efforts by revealing determinants of drug sensitivity.

For more information, visit our lab website.

Current Appointments & Affiliations


Assistant Professor of Pharmacology and Cancer Biology · 2024 - Present Pharmacology & Cancer Biology, Basic Science Departments
Member of the Duke Cancer Institute · 2025 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published July 11, 2024
PCB Appoints Two New Tenure-Track Faculty Members

View All News

Recent Publications


Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress.

Journal Article Dev Cell · August 19, 2024 Control of cellular identity requires coordination of developmental programs with environmental factors such as nutrient availability, suggesting that perturbing metabolism can alter cell state. Here, we find that nucleotide depletion and DNA replication s ... Full text Link to item Cite

A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments.

Journal Article Nat Cell Biol · May 2024 Blocking the import of nutrients essential for cancer cell proliferation represents a therapeutic opportunity, but it is unclear which transporters to target. Here we report a CRISPR interference/activation screening platform to systematically interrogate ... Full text Open Access Link to item Cite
View All Publications

Education, Training & Certifications


Swiss Federal Institute of Technology-EPFL Lausanne (Switzerland) · 2010 Ph.D.